What is the mechanism of action of this treatment?

Anesthesia treatments commonly involve agents such as propofol, sevoflurane, and fentanyl, which work through various mechanisms to induce unconsciousness, analgesia, and muscle relaxation. Propofol enhances the inhibitory neurotransmitter GABA, leading to sedation and hypnosis. Sevoflurane, an inhalational agent, modulates ion channels to produce a reversible loss of consciousness. Fentanyl, an opioid, binds to mu-opioid receptors to provide potent analgesia. These mechanisms are crucial for anesthesia patients as they ensure a pain-free and immobile state during surgery, allowing for precise and safe surgical interventions. The emphasis on skill acquisition and competency through methods like J-I-T RCDP Simulation Training is vital as it ensures that anesthesia providers can effectively and safely administer these agents, manage potential complications, and improve patient outcomes.

What side effects are associated with this type of intervention?

Common side effects of general anesthesia include nausea, vomiting, sore throat, muscle aches, confusion, and shivering. Serious but less common side effects can include allergic reactions, postoperative delirium, and cognitive dysfunction. Intubation, often practiced in anesthesia training, can cause sore throat, vocal cord damage, and, rarely, aspiration or tracheal injury.

What prior FDA approvals exist?

The FDA has approved several drugs for anesthesia that are commonly used in clinical practice to ensure effective and safe patient management. These include propofol, a widely used intravenous anesthetic known for its rapid onset and short duration of action, and remifentanil, an opioid analgesic with a quick onset and short half-life, making it suitable for procedures requiring rapid recovery. Both drugs are often used in combination for balanced anesthesia, providing both sedation and pain relief. These medications are relevant to the Just-In-Time (J-I-T) Rapid Cycle Deliberate Practice (RCDP) Simulation Training, which aims to enhance anesthesia trainees' skills through repetitive practice and immediate feedback, ensuring they are well-prepared for real-world clinical scenarios.

What other types of research exist?

Promising alternatives to J-I-T RCDP Simulation Training for anesthesia patients include Virtual Reality (VR) Simulation, Augmented Reality (AR) Training, and Artificial Intelligence (AI)-Driven Personalized Learning Platforms. VR and AR provide immersive, interactive environments for practicing anesthesia procedures, while AI-driven platforms offer tailored feedback and adaptive learning experiences.

← Back to Search

Behavioural Intervention

Simulation Airway Coaching for Anesthesia Trainee Skills

N/A

Waitlist Available

Led By Stephen Flynn, MD

Research Sponsored by Boston Children's Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, anticipated 12-15 months

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to see if a special training method can help new pediatric anesthesia trainees perform better at helping infants breathe. The trainees will practice with guidance to improve their skills. The goal is to make sure they can successfully help infants breathe on the first try, reducing potential complications.

Who is the study for?

This trial is for novice pediatric anesthesia trainees, specifically fellows and residents in that field. It's not open to medical students or off-service rotators who are temporarily working in different specialties.

What is being tested?

The study is testing a training method called Just-In-Time Rapid Cycle Deliberate Practice Simulation. This method aims to improve the skills of new pediatric anesthesia trainees in performing laryngoscopy, which is a procedure used to view someone's vocal cords.

What are the potential side effects?

Since this trial involves educational simulation training rather than medication or invasive procedures, there aren't any direct medical side effects associated with it.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, anticipated 12-15 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, anticipated 12-15 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, anticipated 12-15 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

1st attempt success rate

Secondary study objectives

Cognitive Load in intubating patient

Complication rate

Evaluation of utility of JIT/RCDP

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: ExperimentalExperimental Treatment1 Intervention

The experimental group will review a pre-induction airway management plan for their upcoming case and undergo a scripted 10-minute RCDP session with an airway coach within 1 hour of patient intubation. The intubation approach (DL vs. video assisted DL) will be chosen by the primary case attending and communicated to the airway coach to simulate the planned laryngoscopy attempt. The experimental group will then proceed with their scheduled case with a member of the research team observing the laryngoscopy attempt(s) to capture data.

Group II: ControlActive Control1 Intervention

The trainees in the control group will have no interventions by the research team, only observation of the intubation and documentation of the same details.

Do I qualify?Apply below to find out

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.

Mechanism Of Action

Side Effect Profile

Prior Approvals

Other Research

Anesthesia treatments commonly involve agents such as propofol, sevoflurane, and fentanyl, which work through various mechanisms to induce unconsciousness, analgesia, and muscle relaxation. Propofol enhances the inhibitory neurotransmitter GABA, leading to sedation and hypnosis. Sevoflurane, an inhalational agent, modulates ion channels to produce a reversible loss of consciousness. Fentanyl, an opioid, binds to mu-opioid receptors to provide potent analgesia. These mechanisms are crucial for anesthesia patients as they ensure a pain-free and immobile state during surgery, allowing for precise and safe surgical interventions. The emphasis on skill acquisition and competency through methods like J-I-T RCDP Simulation Training is vital as it ensures that anesthesia providers can effectively and safely administer these agents, manage potential complications, and improve patient outcomes.

The planning of a clinical trials workshop.Freestyle Deliberate Practice Cadaveric Hand Surgery Simulation Training for Orthopedic Residents: Cohort Study.Usability of a perioperative medication-related clinical decision support software application: a randomized controlled trial.